We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$8.44B
AUM Growth
+$1.09B
Cap. Flow
+$577M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$123M
2
HES
Hess
HES
+$115M
3
ATVI
Activision Blizzard
ATVI
+$108M
4
COR icon
Cencora
COR
+$106M
5
MSFT icon
Microsoft
MSFT
+$101M

Sector Composition

Rank Sector Weight
1 Healthcare 37.55%
2 Technology 28%
3 Industrials 9.43%
4 Energy 7.74%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
351
Arrowhead Research
ARWR
$12.6B
$3.42M 0.04%
95,967
-496,271
-84% -$17.1M
CALY
352
Callaway Golf Company
CALY
$3.52B
$3.42M 0.04%
+172,130
New +$3.44M
PEN icon
353
Penumbra
PEN
$12.8B
$3.41M 0.04%
+9,906
New +$3.04M
CPRX
354
DELISTED
Catalyst Pharmaceutical
CPRX
$3.4M 0.04%
+253,325
New +$3.65M
GFS icon
355
GlobalFoundries
GFS
$28.5B
$3.4M 0.04%
52,632
-157,411
-75% -$9.53M
MUA icon
356
BlackRock MuniAssets Fund
MUA
$515M
$3.37M 0.04%
330,744
+635
+0.2% +$6.53K
PLAY icon
357
Dave & Buster's
PLAY
$369M
$3.33M 0.04%
74,705
+983
+1% +$35.9K
DNLI icon
358
Denali Therapeutics
DNLI
$3.84B
$3.31M 0.04%
112,212
+11,901
+12% +$335K
ENX
359
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$3.28M 0.04%
348,976
+10,951
+3% +$104K
NBXG
360
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.21B
$3.27M 0.04%
299,999
-21,902
-7% -$221K
RENE
361
DELISTED
Cartesian Growth Corp II
RENE
$3.2M 0.04%
300,000
CITE
362
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$3.19M 0.04%
300,000
GOGN
363
DELISTED
GoGreen Investments Corporation
GOGN
$3.19M 0.04%
300,000
NFNT
364
DELISTED
Infinite Acquisition Corp.
NFNT
$3.17M 0.04%
299,999
SVII
365
DELISTED
Spring Valley Acquisition Corp II
SVII
$3.16M 0.04%
300,000
RLAY icon
366
Relay Therapeutics
RLAY
$4.26B
$3.14M 0.04%
250,000
-25,000
-9% -$311K
CBAY
367
DELISTED
Cymabay Therapeutics
CBAY
$3.13M 0.04%
285,717
SG icon
368
Sweetgreen
SG
$679M
$3.11M 0.04%
+242,880
New +$2.25M
HWEL
369
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$3.08M 0.04%
300,000
CNDA
370
DELISTED
Concord Acquisition Corp II
CNDA
$3.08M 0.04%
300,000
IRON icon
371
Disc Medicine
IRON
$2.99B
$3.03M 0.04%
+68,146
New +$2.42M
MLYS icon
372
Mineralys Therapeutics
MLYS
$2.34B
$2.98M 0.04%
175,000
SHOE
373
Shoe Station Group
SHOE
$422M
$2.97M 0.04%
126,564
+107,756
+573% +$2.47M
BSTZ icon
374
BlackRock Science and Technology Term Trust
BSTZ
$2.05B
$2.94M 0.03%
162,077
INMD icon
375
InMode
INMD
$883M
$2.92M 0.03%
78,117
-956
-1% -$33.4K

Similar funds

Woodline Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.

  • Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
  • Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
  • Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
  • Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
  • Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
  • Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
  • Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.